DPDPaste a Video URL
Dependant Personality Disorder (DPD)
Author Archives: Dialectic Behavioural Therapy (DBT)
Clearview Treatment Programs Sponsors Several Upcoming Borderline Personality Disorder Events – Press Release – Digital Journal
On May 3, 2013, mental health professionals will gather at the Linehan Institute Spring Luncheon in New York to celebrate and honor the work of Marsha Linehan, Ph.D. Dr. Linehan developed Dialectical Behavior Therapy DBT, a highly effective, evidence-based treatment for Borderline Personality Disorder. More information on the luncheon can be found online at linehaninstitute.org.
The Management and Treatment of Personality Disorder Conference: Evidence Updates
This conference on June 6 will help healthcare and other professionals to maximise their treatment impact by learning about the current evidence-based best practices for working with people with personality disorder. Through presentations by and discussions with experts in the field, delegates will gain a greater understanding of the issues relevant to the management and treatment of this client group.The conference format offers opportunities for delegates to ask questions about issues important to them, and those attending should come prepared to raise points for open discussion.The intended outcome of this event is that delegates will be better informed about personality disorder and so will be able to design and deliver interventions that are of maximum benefit for service users. The conference will highlight the following: The health burden of personality disorderWhat works with personality disorderPharmacotherapy with personality disorderService user led initiativesCompetencies for working with people with personality disorderPerspectives from service usersThe therapeutic value of creative approaches in treatmentIntegrated treatmentThe day will be chaired by Mary McMurran who is Professor of Personality Disorder Research at the University of Nottinghams Institute of Mental Health.Emergence Managing Director Kath Lovell will also be speaking at the event – her presentation will focus on service user led initiatives. Nearer the time, we will provide more details about Kaths speech.For more information please go to the conference organisers, Medineo, website or open the Conference flyer.
via The Management and Treatment of Personality Disorder Conference: Evidence Updates.
Society for Dialectical Behaviour Therapy
Anyone trained in DBT may be interested in joining the newly formed Society for Dialectical Behaviour Therapy
Taylor & Francis Online report Schema Therapy for Forensic Patients with Personality Disorders: Design and Preliminary Findings of a Multicenter Randomized Clinical Trial in the Netherlands
According to Dutch Law, patients committing severe crimes justifying imprisonment of four years or more who cannot be held (fully) accountable for these acts can be sentenced to compulsory hospitalization in a specialized TBS hospital in the Netherlands. In the current paper, the effects of TBS treatment will be addressed in terms of recidivism numbers after termination of TBS treatment, as well as in behavioral changes that are observed during admission to TBS hospitals. Although these results offer some indirect support suggesting that TBS is effective, no randomized controlled trials had been conducted up until now that could confirm this. In the current study, preliminary results are reported from a multicenter randomized clinical trial on the effectiveness of Schema Therapy (ST) for hospitalized TBS patients with Antisocial, Borderline, Narcissistic, or Paranoid Personality Disorders, including those with high levels of psychopathy. Patients at seven TBS clinics were randomly assigned to receive three years of either ST or Treatment As Usual (TAU), and are being assessed on several outcome variables, such as recidivism risk (HCR-20, START), personality disorder symptoms (SIDP-IV, SNAP), and successful re-integration into the community. A three-year follow-up study will examine actual recidivism. One hundred and two patients are participating in the study. The preliminary findings from the first 30 patients to complete the three-year study suggest that ST is yielding better outcomes than TAU with regard to reducing recidivism risk and promoting re-entry into the community. These findings are not yet statistically significant, and thus need to be interpreted with caution until confirmed in our complete sample and follow up. However, they suggest that ST may be a promising treatment for offenders with personality disorders, including some psychopathic ones
International Journal of Forensic Mental Health
Volume 11, Issue 4, 2012
Special Issue: The 2nd Bergen Conference on the Treatment of Psychopathy
Borderline Personality Disorder May Delay Depression Remission
Depression can be challenging to treat. Whether it is approached with interpersonal psychotherapy (IPT), cognitive behavioral therapy (CBT), mindfulness-based therapy, medication, or a combination of treatments, some individuals with depression endure significant symptoms. The presence of another psychological problem, such as anxiety, posttraumatic stress, or phobia, can make it even more difficult to achieve remission. In a recent study, Jessica C. Levenson of the University of Pittsburgh’s Department of Psychology examined whether personality disorders affected treatment outcomes for depression. She also wanted to determine if the type of treatment administered strengthened or weakened any affect.
Levenson enlisted 275 individuals with major depression and enrolled them in a treatment protocol that consisted of IPT or medication. She evaluated the participants for symptom severity and comorbidity of borderline personality disorder and then gauged remission rates from treatment conclusion to three months post-treatment. She found that the participants who had only one personality disorder did not have lower remission rates than those with no comorbid conditions. However, individuals with multiple dimensions of personality took longer to achieve remission, regardless of whether they received IPT or medication. “The findings support our hypothesis that a higher level of personality pathology is related to longer time to remission from depression, with borderline personality pathology carrying the majority of this effect,” Levenson said.
The results of this study shed some light on factors that may contribute to treatment resistance in people with depression. Even if they have never been diagnosed with borderline personality disorder, the existence of symptoms related to that could impair treatment success. Levenson cautions that changes to the upcoming DSM-V could make identification of those at risk for personality disorders even more difficult. With respect to these findings, she notes that they should be considered in light of their limitations, which include a short follow-up period and primarily white participant sample. Despite those shortcomings, Levenson believes that these results have important implications and could help clinicians be prepared for treatment resistance and extended durations of time for clients with depression and borderline personality disorder to achieve remission.
Reference:
Levenson, Jessica C., Meredith L. Wallace, Jay C. Fournier, Paola Rucci, and Ellen Frank. The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy. Journal of Consulting and Clinical Psychology 80.5 (2012): 719-29. Print.
via Borderline Personality Disorder May Delay Depression Remission.
Personality Disorder Therapy 